A 51-year-old active smoker with primary acquired pulmonary alveolar proteinosis (PAP) diagnosed by biopsy and anti-GM-CSF antibodies was treated safely with whole-lung lavage (WLL). This resulted in a rapid improvement of symptoms and arterial blood oxygenation, but not of standard lung function parameters. However, we also performed the multiple-breath nitrogen washout (MBW) test to determine the lung clearance index (LCI) as well as indices of acinar ventilation heterogeneity (Sacin) and conductive ventilation heterogeneity (Scond). At baseline, a distinct abnormality was seen for Sacin and LCI, while Scond was at the upper limit of normal for this subject. Sacin, in particular, was in excess of the Sacin abnormality corresponding to a 20-pack-year smoking history. Immediately after WLL, Sacin and Scond both fell to within a normal range while LCI also decreased but remained abnormal. The Sacin decrease was much greater than the Scond decrease, which was to be expected after 1 week of smoking cessation at the hospital (smoking was resumed after release from hospital). A follow-up visit 7 weeks after WLL revealed a spectacular improvement on CT scan and improvements in standard lung function. Another follow-up visit 14 weeks after WLL showed further improvements in standard lung function, and both Sacin and Scond remained well within the normal range, and LCI was above the upper limit of normal. We conclude that in this patient, removal of excess surfactant by WLL resulted in a restored ventilation distribution in most of the distal air spaces.

• Whole-lung lavage is the common interventional treatment for pulmonary alveolar proteinosis. Standard follow-up methods include lung function parameters and radiological exams.

• In addition to the standard tests, we used a state-of-the-art analysis of the multiple-breath nitrogen washout test, yielding the indices Scond and Sacin as measures of ventilation heterogeneity at the level of the conductive and acinar air spaces, respectively. These parameters showed markedly abnormal acinar ventilation distribution at baseline, which returned to within the limits of normal immediately after lavage.

Pulmonary alveolar proteinosis (PAP) is an uncommon disease characterized by the accumulation of PAS-positive lipoproteinaceous material in the distal air spaces with preserved alveolar architecture [1].

We present a case of primary acquired PAP in a patient, known to have end-stage renal failure and factor V Leiden deficiency, successfully treated with whole-lung lavage (WLL). The outcome was quantified with lung function tests, including a multiple breath washout (MBW) to study ventilation distribution [2]. In the adult human lung, this test distinguishes between ventilation heterogeneity in the conductive lung zone (Scond; induced by purely convective gas transport) and ventilation heterogeneity in the acinar lung zone (Sacin; induced by diffusion-convection interaction beyond the acinar entrance).

A 51-year-old male patient, on peritoneal dialysis because of end-stage renal failure due to biopsy-proven nephrangiosclerosis and known to have factor V Leiden deficiency, presented for a work-up prior to a kidney transplantation. He was an active smoker with a 20-pack-year smoking history. Laboratory tests showed renal failure and an elevated LDH level (556 U/l). Chest CT scan revealed ground-glass opacification with a thickening of intralobular and interlobular structures, in a crazy-paving pattern (fig. 1a) and with no signs of emphysema. Pulmonary function tests showed a mild restriction (TLC = 79% predicted), but neither obstruction (FEV1/FVC 78%) nor air-trapping (FVC = 98% pred.) (table 1). Diffusing capacity was reduced [TLCO adjusted for hemoglobin (Hb adj) = 57% pred.; Hb adj = 13.3 g/dl]. VATS biopsy revealed preserved alveolar architecture with accumulation of lipoproteinaceous material in the air spaces (fig. 2). Anti-GM-CSF antibodies were identified in a referral lab (40 µg/ml, n < 10 µg/ml), confirming the diagnosis of primary acquired PAP. Given the high rate of spontaneous remission in PAP and because the patient was asymptomatic, we decided not to start any treatment at the time of diagnosis.

Table 1

Lung function values at diagnosis and up to 14 weeks post whole lung lavage

Lung function values at diagnosis and up to 14 weeks post whole lung lavage
Lung function values at diagnosis and up to 14 weeks post whole lung lavage
Fig. 1

CT scanning of the chest before (a) and after (b) WLL.

Fig. 1

CT scanning of the chest before (a) and after (b) WLL.

Close modal
Fig. 2

VATS biopsy shows preserved alveolar architecture with accumulation of lipoproteinaceous material in the air spaces.

Fig. 2

VATS biopsy shows preserved alveolar architecture with accumulation of lipoproteinaceous material in the air spaces.

Close modal

One year after establishing the PAP diagnosis, the patient presented with progressive dyspnoea. He was an active smoker at the time. His LDH level was 841 U/l and chest CT revealed more pronounced reticulonodular opacities. On pulmonary function tests, both ventilatory restriction and diffusion impairment had worsened [TLC = 62% pred.; TLCO (Hb adj) = 39% pred.]. Arterial oxygen saturation was 86%. From figure 3, it can be inferred that the most marked degree of abnormality in ventilation heterogeneity was observed for most of the distal air spaces (Sacin = 184% pred.) as opposed to that in the conductive air spaces (Scond was at the level of its upper limit of normal for a 52-year-old never-smoker). The predicted normal Sacin, Scond and LCI values and limits of normal were based on a local cohort of 120 never-smokers (50% males) evenly distributed across the age range 25–65 years [3].

Fig. 3

a Sacin at time of PAP diagnosis and at 3 time points during a 14-week follow-up; the grey area delimits the zone of normality (upper and lower limit of normal for a male subject of the same age based on a local database). b Scond during a 14-week follow-up. c LCI during a 14-week follow-up. In b and c the representation is the same as in a.

Fig. 3

a Sacin at time of PAP diagnosis and at 3 time points during a 14-week follow-up; the grey area delimits the zone of normality (upper and lower limit of normal for a male subject of the same age based on a local database). b Scond during a 14-week follow-up. c LCI during a 14-week follow-up. In b and c the representation is the same as in a.

Close modal

Because of the progression of the disease, we decided to perform a WLL, using a double-lumen endotracheal tube. Twenty-one 1-liter aliquots of normal saline (warmed to body temperature) were used for the left lung. The initial effluent was very milky in appearance and became progressively less opaque. The weight gain of the patient was limited and he did not need ultrafiltration. Three days after the first procedure, WLL of the right lung was performed using a total of 17 liters of normal saline. No bleeding complications occurred.

Three days after WLL, standard lung function parameters had not yet changed [TLC = 61% pred., TLCO (Hb adj) = 38% pred.), while Sacin and Scond had already decreased, by 60 and 29% of respective baseline values in this patient, to within the normal range. The PaO2 and oxygen saturation had also returned to normal immediately after WLL. Nine days after WLL, the patient was discharged from the hospital, no longer in need of any oxygen supplements. While he was subject to the smoking ban within the hospital, he returned to being an active smoker after hospital discharge.

Seven weeks later the patient presented for follow-up. He had not experienced any respiratory symptoms, and standard lung function parameters showed an improvement [TLC = 75% pred., TLCO (Hb adj) = 56% pred.]. While Sacin and Scond had increased slightly, both values were still in the normal range and very close to the predicted values for this subject (table 1, fig. 3). Arterial oxygen saturation on room air was 98%. CT scan of the chest showed a spectacular decrease of the interstitial pattern (fig. 1b). After another 7 weeks, standard lung function was seen to be further improved, while Sacin remained stable and only Scond continued to slightly increase, nevertheless remaining within the normal range.

PAP is an uncommon disease characterized by the accumulation of PAS-positive lipoproteinaceous material in the distal air spaces, with negligible inflammation [1]. This case of primary acquired PAP in a patient with end-stage renal failure was safely treated with WLL.

First performed in 1960, the success of WLL is presumed to be due to the physical removal of the excess surfactant, allowing for functional improvement. A review of 47 patients showed a favorable therapeutic response in PaO2, P(A-a)O2 gradient, FEV1 and TLCO in 85% of the patients [1]. Signs of improvement are radiographic clearing, decreased LDH levels and increased ventilation/perfusion matching. A review of 38 cases in Korea and of 21 in Italy showed consistent improvements in PaO2, (A-a)O2 and TLCO after WLL, while FVC and TLC responses were variable [4,5]. In our patient, we saw an improvement of TLC, TLCO and PaO2. The parameters for ventilation distribution, Sacin and Scond, showed an early improvement at a time when standard lung function had not yet signaled any notable change.

Lung volumes (FRC and TLC) showed a delayed improvement and, in fact, remained low throughout the observation period. This could possibly be due to an engorgement of the lympathic vessels after WLL and to the presence of some residual fluid in the alveolar spaces affecting lung compliance. Abnormal compliance of relatively large lung units may also be at the basis of the relatively high LCI values throughout the study, yet LCI could also be enhanced due to irreversible smoking-induced small airway dysfunction. Since the quantitative effect of smoking history on LCI has not been documented and it is intrinsically impossible to attribute LCI to large or small lung units, we cannot speculate on the likelihood of either explanation.

The difficulty with establishing abnormality of small airway function in this patient was that he was an active smoker. Based on a previous MBW study in smokers [2], typical Sacin and Scond values in a smoker with 20 pack-years amount to 125 and 132% of their normal predicted value, respectively. So for this particular patient, his personal best values for Sacin and Scond could be estimated as 0.138/liter and 0.048/liter respectively, i.e. close to the Sacin and Scond value obtained after 14 weeks (fig. 3). We cannot exclude the possibility that part of the initial Sacin and Scond decrease may have been due to an episode of reduced smoking during the hospital stay. However, the expected effect of 1 week of complete smoking cessation on Sacin and Scond is 16 and 13%, respectively [6], which is considerably smaller than the 60 and 29% decrease seen in figure 3a and b. While it could be argued that the increasing trend of Scond between 7 and 14 weeks was still in part associated with resumed smoking (after only 1 week of smoking cessation), the stabilization of Sacin over the same time interval (fig. 3a) suggests a sustained recovery of ventilation distribution in most of the distal airway spaces of this patient.

There are no demographic or disease-related predictors of successful response to WLL [1] and approximately 15% of the patients will relapse. The observed abnormality of ventilation heterogeneity in most of the distal lung spaces and its marked response after WLL suggest that the MBW test may be a helpful additional noninvasive tool for monitoring PAP patients during follow-up in various intervention strategies.

1.
Seymour J, Presneill J: Pulmonary alveolar proteinosis. Progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215–235.
2.
Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W: Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med 2004;170:414–419.
3.
Verbanck S, Thompson BR, Schuermans D, Kalsi H, Biddiscombe M, Stuart-Andrews C, Hanon S, Van Muylem A, Paiva M, Vincken W, Usmani O: Ventilation heterogeneityin the acinar and conductive zones of the normal ageing lung. Thorax 2012, E-pub ahead of print, PubMed PMID: 22544894.
4.
Byun M, Kim D, Kim Y, Chung M, Shim J, Cha S, Uh S, Park C, Jeong S, Park Y, Lee H, Park M: Clinical features and outcome of idiopathic pulmonary alveolar proteinosis in Korean population. J Korean Med Sci 2010;25:393–398.
5.
Beccaria M, Luisetti M, Rodi G, Corsico A, Zoia MC, Colato S, Pochetti P, Braschi A, Pozzi E, Cerveri I: Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J 2004;23:526–531.
6.
Verbanck S, Schuermans D, Paiva M, Meysman M, Vincken W: Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med 2006;174:853–857.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.